Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: ALGN SYK JNJ ISRG BSX ZBH MDT BAX HOLX STE

| Held by: VTI VOO VB VBR IVV RSP SPY XLV IWR VHT

Index	S&P 500	P/E	35.24	EPS (ttm)	2.02	Insider Own	0.67%	Shs Outstand	195.10M	Perf Week	1.48%
Market Cap	13.89B	Forward P/E	14.16	EPS next Y	5.03	Insider Trans	1.24%	Shs Float	193.81M	Perf Month	-3.44%
Enterprise Value	16.27B	PEG	1.45	EPS next Q	1.10	Inst Own	104.84%	Short Float	3.37%	Perf Quarter	-14.34%
Income	401.40M	P/S	3.35	EPS this Y	12.06%	Inst Trans	-0.94%	Short Ratio	3.19	Perf Half Y	1.35%
Sales	4.15B	P/B	1.66	EPS next Y	8.95%	ROA	3.26%	Short Interest	6.53M	Perf YTD	-13.12%
Book/sh	42.87	P/C	111.15	EPS next 5Y	9.77%	ROE	4.87%	52W High	89.83 -20.73%	Perf Year	-5.52%
Cash/sh	0.64	P/FCF	28.29	EPS past 3/5Y	-1.15% 9.30%	ROIC	3.92%	52W Low	61.78 15.27%	Perf 3Y	-23.04%
Dividend Est.	-	EV/EBITDA	14.85	Sales past 3/5Y	7.35% 10.98%	Gross Margin	60.69%	Volatility	1.92% 2.47%	Perf 5Y	-26.22%
Dividend TTM	-	EV/Sales	3.92	EPS Y/Y TTM	-2.65%	Oper. Margin	17.19%	ATR (14)	1.88	Perf 10Y	83.52%
Dividend Ex-Date	Jul 26, 2023	Quick Ratio	0.79	Sales Y/Y TTM	5.69%	Profit Margin	9.67%	RSI (14)	42.73	Recom	2.10
Dividend Gr. 3/5Y	- -	Current Ratio	1.34	EPS Q/Q	28.28%	SMA20	0.64%	Beta	1.05	Target Price	90.93
Payout	0.00%	Debt/Eq	0.30	Sales Q/Q	6.16%	SMA50	-7.35%	Rel Volume	0.72	Prev Close	71.46
Employees	15000	LT Debt/Eq	0.22	Earnings	Mar 05 AMC	SMA200	-4.59%	Avg Volume	2.04M	Price	71.21
IPO	Jan 21, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.79% 0.01%	Trades		Volume	1,471,814	Change	-0.35%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-04-26	Downgrade	Rothschild & Co Redburn	Buy → Neutral	$85
Feb-03-26	Reiterated	Needham	Buy	$100 → $99
Nov-13-25	Downgrade	Wells Fargo	Overweight → Equal Weight	$72
Oct-13-25	Initiated	Barclays	Overweight	$85
Oct-01-25	Initiated	Goldman	Sell	$64
Aug-28-25	Downgrade	Citigroup	Buy → Neutral	$72
Jul-22-25	Upgrade	BNP Paribas Exane	Neutral → Outperform	$92
Jun-17-25	Upgrade	Needham	Hold → Buy	$94
May-30-25	Downgrade	JP Morgan	Overweight → Neutral	$76
Aug-29-24	Reiterated	Piper Sandler	Overweight	$115 → $120
Jul-16-24	Upgrade	Jefferies	Hold → Buy	$107 → $115
Mar-19-24	Upgrade	Redburn Atlantic	Neutral → Buy	$125
Mar-13-24	Upgrade	JP Morgan	Neutral → Overweight	$100 → $120
Feb-06-24	Resumed	KeyBanc Capital Markets	Sector Weight
Oct-30-23	Initiated	BofA Securities	Buy	$380
Oct-05-23	Downgrade	Redburn Atlantic	Overweight → Neutral	$390 → $343
May-30-23	Initiated	Morgan Stanley	Equal-Weight	$410
Dec-22-22	Initiated	Mizuho	Buy	$375
Nov-30-22	Upgrade	Robert W. Baird	Neutral → Outperform	$345 → $375
Oct-12-22	Downgrade	Jefferies	Buy → Hold	$400 → $295

Show Previous Ratings

Apr-09-26 08:05AM	CooperVision Launches MADE BETTER Promise Beginning with MyDay Contact Lenses*¹ (PR Newswire)
Mar-17-26 08:19AM	Is Cooper Companies Stock Underperforming the Dow? (Barchart)
Mar-13-26 11:55AM	How Is West Pharmaceutical's Stock Performance Compared to Other Healthcare Stocks? (Barchart)
Mar-09-26 05:24PM	CooperCompanies Insiders Buy as Rebound Setup Forms (MarketBeat)
09:40AM	Why The Cooper Companies (COO) is a Top Value Stock for the Long-Term (Zacks)
09:15AM	Loading…
09:15AM	Investing in The Cooper Companies (COO)? Don't Miss Assessing Its International Revenue Trends (Zacks)
Mar-07-26 08:15AM	Cooper Companies price target raised to $101 from $99 at Needham (TipRanks)
Mar-06-26 04:42PM	Stocks Retreat on Inflation Concerns and a Weak US Job Market (Barchart)
12:45PM	Is The Cooper Companies (COO) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
11:18AM	Stocks Retreat Amid Inflation Fears and Weak US Jobs (Barchart)
10:45AM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
10:05AM	Stocks Slump on Iran War and Weak US Jobs Report (Barchart)
09:45AM	Here's Why The Cooper Companies (COO) is a Strong Growth Stock (Zacks)
09:20AM	COO Q4 Deep Dive: Margin Gains Offset Slower Organic Growth and Asia Pacific Pressures (StockStory)
09:14AM	COO Declines Despite Q1 Earnings Beat and Raised FY26 Outlook (Zacks)
08:30AM	Loading…
08:30AM	The Cooper Companies, Inc. Q1 2026 Earnings Call Summary (Moby)
06:29AM	Marvell shares climb after earnings and other stocks on the move (MarketWatch)
03:05AM	NCC 2026: CooperVision Research Supports a Lifetime of Clear, Comfortable Contact Lens Wear (PR Newswire)
12:01AM	The Cooper Companies Inc (COO) Q1 2026 Earnings Call Highlights: Strong Start with Increased ... (GuruFocus.com)
Mar-05-26 08:18PM	Cooper Companies Q1 Earnings Call Highlights (MarketBeat)
06:00PM	The Cooper Companies (COO) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
05:30PM	The Cooper Companies (COO) Q1 Earnings Surpass Estimates (Zacks)
04:33PM	CooperCompanies (NASDAQ:COO) Reports Q4 CY2025 In Line With Expectations (StockStory)
04:15PM	CooperCompanies Announces First Quarter 2026 Results (GlobeNewswire)
Mar-04-26 09:39AM	Roblox initiated, Target upgraded: Wall Street's top analyst calls (The Fly)
07:59AM	Earnings To Watch: CooperCompanies (COO) Reports Q4 Results Tomorrow (StockStory)
07:54AM	Here Are Wednesdays Top Wall Street Analyst Research Calls: Dow, First Solar, GM, GitLab, Roblox, Ross Stores, Target, Tesla, Toll Brothers, and More (24/7 Wall St.)
Mar-03-26 05:15PM	Staar Surgical (STAA) Lags Q4 Earnings and Revenue Estimates (Zacks)
Mar-02-26 09:36AM	Cooper Companies to Post Q1 Earnings: Is a Beat in the Offing? (Zacks)
09:15AM	What Analyst Projections for Key Metrics Reveal About The Cooper Companies (COO) Q1 Earnings (Zacks)
10:00AM	Loading…
Feb-26-26 10:00AM	The Cooper Companies (COO) Earnings Expected to Grow: Should You Buy? (Zacks)
Feb-25-26 08:28AM	What Makes Cooper Companies (COO) an Investment Choice? (Insider Monkey)
Feb-24-26 07:30PM	Merit Medical (MMSI) Q4 Earnings and Revenues Top Estimates (Zacks)
12:31PM	Will Medline's Q4 Earnings Validate Its Prime Vendor Growth Strategy? (Zacks)
08:31AM	BrightSpring to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
Feb-23-26 08:46AM	DENTSPLY SIRONA to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
08:45AM	Solventum to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
Feb-18-26 07:42AM	Cooper Companies Stock: Is Wall Street Bullish or Bearish? (Barchart)
Feb-17-26 01:44PM	Insiders Piled Into These 3 Stocks in Q4-One Stands Out (MarketBeat)
09:27AM	Beat the Market the Zacks Way: Micron Technology, Cooper Companies, Coeur Mining in Focus (Zacks)
Feb-13-26 11:40AM	COO vs. WST: Which Stock Is the Better Value Option? (Zacks)
Feb-11-26 01:34PM	BD Merges Biosciences & Diagnostics Business With Waters (Zacks)
Feb-10-26 09:23AM	The Cooper Companies (COO) Moved Higher as Multiple Tailwinds Align (Insider Monkey)
Feb-05-26 04:15PM	CooperCompanies Announces Release Date for First Quarter 2026 (GlobeNewswire)
Feb-04-26 05:20PM	Align Technology (ALGN) Surpasses Q4 Earnings and Revenue Estimates (Zacks)
Feb-03-26 01:17PM	Reasons to Add Cooper Companies Stock to Your Portfolio Now (Zacks)
12:10PM	Will The Cooper Companies (COO) Beat Estimates Again in Its Next Earnings Report? (Zacks)
08:05AM	Diamond Hill Large Cap Fund Purchased Cooper Companies (COO) Betting on the Resilient Contact Lens Industry (Insider Monkey)
Feb-02-26 11:57AM	BD & Envetec Showcase Closed-Loop Recycling Solution for Lab Plastics (Zacks)
Jan-29-26 11:38PM	1 Healthcare Stock to Own for Decades and 2 We Question (StockStory)
12:17PM	CONMED Stock Up Post Q4 Earnings and Revenue Beat, Gross Margin Up (Zacks)
Jan-28-26 11:40AM	COO vs. WST: Which Stock Should Value Investors Buy Now? (Zacks)
Jan-27-26 12:19PM	Here's Why You Should Add Merit Medical Stock to Your Portfolio Now (Zacks)
09:45AM	Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term (Zacks)
Jan-26-26 09:40AM	Here's Why The Cooper Companies (COO) is a Strong Value Stock (Zacks)
Jan-23-26 01:50PM	WST Launches Synchrony S1 Prefillable Syringe at Pharmapack (Zacks)
07:57AM	What You Need to Know Ahead of The Cooper Companies' Earnings Release (Barchart)
Jan-22-26 11:08AM	Here's Why You Should Retain Integer Holdings Stock in Your Portfolio (Zacks)
10:43AM	BD and Ypsomed Expand Partnership to Target Growing Biologics Market (Zacks)
Jan-21-26 11:43AM	BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System (Zacks)
Jan-14-26 12:50PM	Reasons to Add West Pharmaceutical Stock to Your Portfolio Now (Zacks)
Jan-13-26 11:16AM	Judge Denies Teva Bid To Pause Paragard Copper Contraceptive Device Lawsuit Trial (Benzinga)
Jan-12-26 11:40AM	COO or WST: Which Is the Better Value Stock Right Now? (Zacks)
Jan-07-26 03:00PM	40 stocks likely to outperform in 2026: Boyar pres. explains (Yahoo Finance Video)
Jan-06-26 08:00AM	CooperVision to Launch MyDay MiSight 1 day Myopia Control Soft Contact Lenses (PR Newswire)
Jan-05-26 07:17AM	Hologic Trading Near 52-Week High: How Should You Play the Stock? (Zacks)
Jan-01-26 10:32PM	Medical Devices & Supplies - Diversified Stocks Q3 In Review: CooperCompanies (NASDAQ:COO) Vs Peers (StockStory)
Dec-31-25 07:36AM	What Makes The Cooper Companies (COO) an Investment Bet? (Insider Monkey)
Dec-30-25 02:04PM	Top Stock Reports for Berkshire Hathaway, AstraZeneca & Intel (Zacks)
07:33AM	Reasons to Add Cooper Companies Stock to Your Portfolio Now (Zacks)
Dec-29-25 04:15PM	CooperCompanies to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-26-25 11:40AM	COO vs. MMSI: Which Stock Is the Better Value Option? (Zacks)
Dec-23-25 08:00AM	CooperCompanies Appoints Walter M Rosebrough, Jr. to its Board of Directors (GlobeNewswire)
Dec-22-25 12:12PM	BD and Penn Institute Ink Collaboration to Advance Immunotherapy (Zacks)
Dec-19-25 09:55AM	The Cooper Companies (COO)'s Technical Outlook is Bright After Key Golden Cross (Zacks)
Dec-16-25 11:05PM	3 Reasons to Sell COO and 1 Stock to Buy Instead (StockStory)
11:37AM	BD Expands BD MAX With IVDR-Approved VIASURE Tests in Europe (Zacks)
Dec-12-25 09:50AM	Why The Cooper Companies (COO) is a Top Momentum Stock for the Long-Term (Zacks)
Dec-11-25 07:34AM	Is The Cooper Companies Stock Underperforming the Nasdaq? (Barchart)
12:31AM	5 Insightful Analyst Questions From CooperCompanies's Q3 Earnings Call (StockStory)
Dec-10-25 11:40AM	COO or MMSI: Which Is the Better Value Stock Right Now? (Zacks)
Dec-08-25 09:40AM	Why The Cooper Companies (COO) is a Top Value Stock for the Long-Term (Zacks)
09:15AM	The Cooper Companies (COO) International Revenue Performance Explored (Zacks)
Dec-05-25 11:11AM	CooperCompanies (COO) Stock Trades Up, Here Is Why (StockStory) +5.67%
11:02AM	Analyst Report: The Cooper Companies, Inc. (Morningstar Research)
09:11AM	COO Gains as Q4 Earnings & Sales Beat Estimates, MyDay Adoption Rises (Zacks)
07:36AM	Warner Bros. shares rise on Netflix deal news, Hewlett Packard Enterprise slumps on earnings and more early market movers (MarketWatch)
02:46AM	Stock Market Today: Dow, S&P 500 and Nasdaq point to gains as investors await Fed's preferred inflation gauge; bitcoin slips, silver surges (MarketWatch)
12:31AM	COO Q3 Deep Dive: Product Momentum and Strategic Review Shape Outlook (StockStory)
12:02AM	The Cooper Companies Inc (COO) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com)
Dec-04-25 06:30PM	The Cooper Companies (COO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:25PM	The Cooper Companies (COO) Q4 Earnings and Revenues Surpass Estimates (Zacks)
04:45PM	CooperCompanies (NASDAQ:COO) Reports Q3 CY2025 In Line With Expectations, Stock Soars (StockStory)
04:20PM	CooperCompanies Announces New Chair of the Board and Strategic Review (GlobeNewswire)
04:15PM	CooperCompanies Announces Fourth Quarter and Full Year 2025 Results (GlobeNewswire)
Dec-03-25 05:15PM	HealthEquity (HQY) Tops Q3 Earnings and Revenue Estimates (Zacks)
12:45PM	Cooper Companies to Post Q4 Earnings: What's in Store for the Stock? (Zacks)
Dec-02-25 10:04PM	What To Expect From CooperCompanies's (COO) Q3 Earnings (StockStory)
Dec-01-25 09:15AM	Curious about The Cooper Companies (COO) Q4 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
06:11AM	1 Profitable Stock to Own for Decades and 2 We Find Risky (StockStory)

The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
WEISS ROBERT S	Director	Apr 01 '26	Option Exercise	0.00	3,654	0	292,599	Apr 06 05:16 PM
Rivas Maria	Director	Apr 01 '26	Option Exercise	0.00	3,322	0	3,322	Apr 06 05:16 PM
Jay Colleen	Director	Apr 01 '26	Option Exercise	0.00	3,322	0	39,907	Apr 06 05:16 PM
Carbone Barbara	Director	Apr 01 '26	Option Exercise	0.00	3,050	0	3,050	Apr 06 05:15 PM
MADDEN TERESA S	Director	Apr 01 '26	Option Exercise	0.00	3,322	0	15,679	Apr 06 05:15 PM
Lucchese Cynthia L	Director	Apr 01 '26	Option Exercise	0.00	3,322	0	12,767	Apr 06 05:14 PM
Kurzius Lawrence Erik	Director	Apr 01 '26	Option Exercise	0.00	3,322	0	11,099	Apr 06 05:14 PM
Jay Colleen	Director	Jan 12 '26	Option Exercise	39.40	7,064	278,322	36,585	Jan 14 04:05 PM
White Albert G III	President & CEO	Jan 08 '26	Option Exercise	0.00	18,340	0	254,491	Jan 12 04:24 PM
Warner Gerard H III	President, CooperVision, Inc.	Jan 08 '26	Option Exercise	0.00	11,518	0	29,837	Jan 12 04:24 PM
Sheffield Holly R	President, CSI	Jan 08 '26	Option Exercise	0.00	8,050	0	47,102	Jan 12 04:23 PM
McBride Daniel G	EVP & Chief Operating Officer	Jan 08 '26	Option Exercise	0.00	12,887	0	76,007	Jan 12 04:23 PM
Andrews Brian G	EVP, CFO & Treasurer	Jan 08 '26	Option Exercise	0.00	3,528	0	10,430	Jan 12 04:22 PM
Lucchese Cynthia L	Director	Dec 22 '25	Buy	84.06	1,784	149,963	9,445	Dec 23 04:08 PM
Rivas Maria	Director	Dec 18 '25	Buy	82.13	1,000	82,130	11,141	Dec 19 04:18 PM
Kurzius Lawrence Erik	Director	Dec 17 '25	Buy	82.50	2,000	165,000	7,777	Dec 17 05:06 PM
Sheffield Holly R	President, CSI	Dec 16 '25	Buy	80.75	1,230	99,322	39,052	Dec 16 06:36 PM
White Albert G III	President & CEO	Dec 16 '25	Buy	80.80	10,000	808,000	236,151	Dec 16 06:36 PM
Kurzius Lawrence Erik	Director	Sep 29 '25	Buy	68.39	2,000	136,780	5,777	Sep 29 08:36 PM
White Albert G III	President & CEO	Sep 05 '25	Buy	68.39	10,000	683,900	226,151	Sep 05 05:10 PM
Warner Gerard H III	President, CooperVision, Inc.	Sep 05 '25	Buy	69.23	1,450	100,384	18,319	Sep 05 04:07 PM
McBride Daniel G	EVP & Chief Operating Officer	Sep 02 '25	Buy	65.04	3,000	195,120	63,120	Sep 02 05:17 PM
Andrews Brian G	EVP, CFO & Treasurer	Sep 02 '25	Buy	65.68	1,525	100,162	22,191	Sep 02 05:16 PM

Open in Screener

OMCL

Omnicell, Inc

Apr 10 • 04:00PM ET

34.40

-1.07 -3.02 %

Healthcare • Health Information Services • USA • NASD

Peers: MDB INSP HSIC MCK PDCO GEHC ADUS EHTH AMWL HSTM

| Held by: IJR VTI VB IWM VBR VXF IJS SPSM IWN FESM

Index	RUT	P/E	796.30	EPS (ttm)	0.04	Insider Own	2.96%	Shs Outstand	45.03M	Perf Week	0.73%
Market Cap	1.56B	Forward P/E	16.48	EPS next Y	2.09	Insider Trans	-3.99%	Shs Float	44.09M	Perf Month	-8.22%
Enterprise Value	1.52B	PEG	1.03	EPS next Q	0.32	Inst Own	104.71%	Short Float	5.67%	Perf Quarter	-32.00%
Income	2.05M	P/S	1.32	EPS this Y	8.10%	Inst Trans	1.64%	Short Ratio	3.91	Perf Half Y	9.38%
Sales	1.18B	P/B	1.26	EPS next Y	19.20%	ROA	0.10%	Short Interest	2.50M	Perf YTD	-24.06%
Book/sh	27.36	P/C	6.23	EPS next 5Y	16.02%	ROE	0.17%	52W High	51.84 -33.64%	Perf Year	10.68%
Cash/sh	5.52	P/FCF	18.51	EPS past 3/5Y	-28.87% -43.00%	ROIC	0.14%	52W Low	22.66 51.81%	Perf 3Y	-42.04%
Dividend Est.	-	EV/EBITDA	16.34	Sales past 3/5Y	-2.94% 5.84%	Gross Margin	42.49%	Volatility	4.20% 4.09%	Perf 5Y	-74.46%
Dividend TTM	-	EV/Sales	1.28	EPS Y/Y TTM	-83.28%	Oper. Margin	0.52%	ATR (14)	1.61	Perf 10Y	26.38%
Dividend Ex-Date	-	Quick Ratio	1.19	Sales Y/Y TTM	6.53%	Profit Margin	0.17%	RSI (14)	43.07	Recom	1.25
Dividend Gr. 3/5Y	- -	Current Ratio	1.40	EPS Q/Q	-113.34%	SMA20	0.61%	Beta	0.84	Target Price	57.43
Payout	0.00%	Debt/Eq	0.17	Sales Q/Q	2.32%	SMA50	-9.59%	Rel Volume	0.51	Prev Close	35.47
Employees	3580	LT Debt/Eq	0.16	Earnings	Feb 05 BMO	SMA200	-4.72%	Avg Volume	639.92K	Price	34.40
IPO	Aug 07, 2001	Option/Short	Yes / Yes	EPS/Sales Surpr.	-19.40% 0.20%	Trades		Volume	325,774	Change	-3.02%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-04-26	Upgrade	BofA Securities	Neutral → Buy	$70
Jan-08-26	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$60
May-14-25	Upgrade	Wells Fargo	Equal Weight → Overweight	$35
Oct-31-24	Downgrade	BofA Securities	Buy → Neutral	$44 → $57
Aug-02-24	Upgrade	Barclays	Underweight → Equal Weight	$26 → $39
Jan-03-24	Initiated	Barclays	Underweight	$33
Nov-03-23	Upgrade	Wells Fargo	Underweight → Equal Weight	$39 → $28
Nov-03-23	Upgrade	Piper Sandler	Neutral → Overweight	$70 → $39
Nov-03-23	Downgrade	BTIG Research	Buy → Neutral
Oct-11-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Sep-26-23	Reiterated	Wells Fargo	Underweight	$56 → $39
Aug-02-23	Downgrade	Piper Sandler	Overweight → Neutral	$66 → $70
Jul-20-23	Downgrade	Wells Fargo	Overweight → Underweight	$65 → $56
Feb-27-23	Upgrade	The Benchmark Company	Hold → Buy	$68
Nov-03-22	Downgrade	The Benchmark Company	Buy → Hold
Sep-16-22	Initiated	KeyBanc Capital Markets	Overweight	$130
Sep-09-22	Initiated	BofA Securities	Buy	$120
Jul-15-22	Initiated	SVB Leerink	Mkt Perform	$124
Dec-06-21	Resumed	Wells Fargo	Overweight	$203
Jun-09-21	Initiated	JP Morgan	Neutral	$146

Show Previous Ratings

Mar-02-26 11:07PM	3 Reasons to Avoid OMCL and 1 Stock to Buy Instead (StockStory)
Feb-28-26 10:07AM	Omnicell, Inc. (OMCL): A Bull Case Theory (Insider Monkey)
Feb-12-26 12:37AM	The Top 5 Analyst Questions From Omnicell's Q4 Earnings Call (StockStory)
Feb-06-26 12:33AM	OMCL Q4 Deep Dive: Product Launches, Tariff Headwinds, and Margin Pressures Shape Outlook (StockStory) -5.14%
Feb-05-26 11:37PM	Omnicell Q4 Earnings Call Highlights (MarketBeat) -16.30%
04:06PM	Loading…
04:06PM	Omnicell Inc (OMCL) Q4 2025 Earnings Call Highlights: Strong Demand and Strategic Innovations ... (GuruFocus.com)
11:56AM	Why Omnicell (OMCL) Shares Are Plunging Today (StockStory)
07:45AM	Omnicell (OMCL) Q4 Earnings Lag Estimates (Zacks)
06:53AM	Omnicell's (NASDAQ:OMCL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations (StockStory)
06:53AM	Omnicell: Q4 Earnings Snapshot (Associated Press Finance)
06:30AM	Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results (Business Wire)
Feb-03-26 10:04PM	Omnicell Earnings: What To Look For From OMCL (StockStory) -5.46%
Feb-01-26 10:31PM	Healthcare Technology for Providers Stocks Q3 Highlights: Omnicell (NASDAQ:OMCL) (StockStory)
Jan-30-26 11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
Jan-29-26 10:00AM	Earnings Preview: Omnicell (OMCL) Q4 Earnings Expected to Decline (Zacks)
03:47AM	Loading…
Jan-22-26 03:47AM	Zacks Industry Outlook Highlights Doximity, 10x Genomics and Omnicell (Zacks)
Jan-21-26 09:53AM	3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes (Zacks)
07:57AM	Tempus AI's Key 2025 Milestones Continue to Gain Industry Attention (Zacks)
Jan-19-26 11:02PM	3 Reasons to Sell OMCL and 1 Stock to Buy Instead (StockStory)
Jan-16-26 09:34AM	Here's Why You Should Hold DexCom Stock in Your Portfolio for Now (Zacks)
Jan-15-26 12:09PM	CLOV Reports MA Membership Growth, Signals GAAP Profitability in 2026 (Zacks)
09:36AM	Reasons to Add Fresenius Medical Stock to Your Portfolio Now (Zacks)
Jan-13-26 12:00PM	All You Need to Know About Omnicell (OMCL) Rating Upgrade to Buy (Zacks)
11:40AM	OMCL vs. HIMS: Which Stock Is the Better Value Option? (Zacks)
08:01AM	Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026 (Business Wire)
Jan-08-26 04:39PM	Stocks Settle Mixed on Sector Rotation (Barchart) +6.62%
01:43PM	Omnicell looks at long-term growth tied to cabinet replacement cycle (Investing.com)
11:23AM	Stock Indexes Mixed on Big Tech Weakness and Higher Bond Yields (Barchart)
Jan-02-26 12:10PM	CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus (Zacks)
Dec-31-25 10:30AM	KRMD Submits 510(k) to Use FreedomEDGE System With Oncology Biologic (Zacks)
09:48AM	Loading…
Dec-29-25 09:48AM	Implied Volatility Surging for Omnicell Stock Options (Zacks)
Dec-23-25 12:35PM	FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform (Zacks)
Dec-17-25 07:58AM	How the OneStep Partnership Could Drive Growth for ZBH Stock (Zacks)
Dec-16-25 10:00AM	Best Momentum Stocks to Buy for Dec. 16 (Zacks)
05:43AM	New Strong Buy Stocks for Dec. 16: MDB, OMCL, and More (Zacks)
Dec-15-25 09:12AM	CVS Stock Gains From Offering MMR Vaccine to South Carolina Residents (Zacks)
Dec-10-25 08:34AM	Is it Worth Retaining NEOG Stock in Your Portfolio for Now? (Zacks)
08:31AM	Phibro Animal Health Stock Climbs 59.6% YTD: What's Driving It? (Zacks)
Dec-09-25 07:28AM	ALGN Stock Rises on Thailand Launch of Invisalign With MAOB (Zacks)
07:27AM	Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now (Zacks)
07:26AM	RMD Stock Set to Gain From FDA Clearance of AI-Enabled Smart Comfort (Zacks)
Dec-08-25 11:40AM	OMCL vs. HIMS: Which Stock Should Value Investors Buy Now? (Zacks) +7.54%
08:00AM	Announcing Omnicell Titan XT, the Next Generation, Automated Dispensing System Designed to Empower Autonomous Medication Management (Business Wire)
07:56AM	PODD Stock Benefits From FDA Approval of Omnipod 5's Enhancements (Zacks)
Dec-07-25 11:34PM	1 Healthcare Stock with Impressive Fundamentals and 2 We Brush Off (StockStory)
Dec-05-25 08:48AM	MDT Stock Set to Benefit From the FDA Clearance of Hugo RAS System (Zacks)
08:31AM	Reasons to Add Omnicell Stock to Your Portfolio Right Now (Zacks)
Dec-04-25 11:30AM	Why Is Clover Health Investments (CLOV) Down 11.6% Since Last Earnings Report? (Zacks)
Dec-03-25 11:30AM	Hims & Hers Health (HIMS) Down 15.1% Since Last Earnings Report: Can It Rebound? (Zacks) +5.25%
Nov-27-25 09:55AM	Wall Street Analysts Think Omnicell (OMCL) Could Surge 30.93%: Read This Before Placing a Bet (Zacks)
Nov-20-25 04:01PM	Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference (Business Wire)
11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
Nov-10-25 09:55AM	Wall Street Analysts Believe Omnicell (OMCL) Could Rally 34.53%: Here's is How to Trade (Zacks)
Nov-04-25 11:40AM	OMCL vs. HIMS: Which Stock Is the Better Value Option? (Zacks)
09:21AM	Buy 5 Stocks With Extensive Robotics Application for the Rest of 2025 (Zacks)
Nov-03-25 12:20PM	Earnings Estimates Moving Higher for Omnicell (OMCL): Time to Buy? (Zacks)
11:40AM	OMCL vs. HIMS: Which Stock Should Value Investors Buy Now? (Zacks)
Oct-30-25 06:45PM	Why Omnicell Stock Crushed the Market Today (Motley Fool) +13.56%
04:31PM	Omnicell Inc (OMCL) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges (GuruFocus.com)
02:35PM	Why Omnicell (OMCL) Stock Is Trading Up Today (StockStory)
07:45AM	Omnicell (OMCL) Q3 Earnings and Revenues Surpass Estimates (Zacks)
06:54AM	Omnicell (NASDAQ:OMCL) Reports Bullish Q3, Stock Soars (StockStory)
06:40AM	Omnicell: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	Omnicell Announces Third Quarter 2025 Financial Results (Business Wire)
Oct-28-25 11:15PM	Omnicell (OMCL) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Oct-27-25 10:00AM	Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-24-25 09:55AM	Wall Street Analysts See a 43.74% Upside in Omnicell (OMCL): Can the Stock Really Move This High? (Zacks)
Oct-23-25 10:00AM	Earnings Preview: Omnicell (OMCL) Q3 Earnings Expected to Decline (Zacks)
09:40AM	Are Investors Undervaluing Omnicell (OMCL) Right Now? (Zacks)
Oct-21-25 10:46PM	Omnicell, Inc. (OMCL): A Bull Case Theory (Insider Monkey)
05:19AM	10x Genomics (TXG) Moves 11.1% Higher: Will This Strength Last? (Zacks)
Oct-17-25 11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
Oct-14-25 03:00PM	NVDA & PLTR Driving AI in Health: Top Health IT Stocks for Q3 Earnings (Zacks)
Oct-07-25 09:40AM	Is Omnicell (OMCL) Stock Undervalued Right Now? (Zacks)
08:23AM	Reasons to Add Omnicell Stock to Your Portfolio Right Now (Zacks)
Oct-06-25 04:01PM	Omnicell to Release Third Quarter 2025 Financial Results on October 30, 2025 (Business Wire)
Oct-02-25 12:43AM	1 Stock Under $50 with Promising Prospects and 2 Facing Challenges (StockStory)
Oct-01-25 11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
09:30AM	BD & Henry Ford Health Tie-Up to Enhance Community Pharmacy Experience (Zacks)
Sep-30-25 10:05AM	OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off? (Zacks)
Sep-18-25 09:40AM	Is Omnicell (OMCL) a Great Value Stock Right Now? (Zacks)
Sep-15-25 11:40AM	OMCL or HIMS: Which Is the Better Value Stock Right Now? (Zacks)
Sep-12-25 03:35AM	The Zacks Analyst Blog Highlights Butterfly Network, Omnicell, NVIDIA, Palantir and IBM (Zacks)
Sep-11-25 03:00PM	NVIDIA, AI & Quantum Leaders Drive Health Tech: 2 Stocks to Buy (Zacks)
09:55AM	Wall Street Analysts Think Omnicell (OMCL) Could Surge 39.36%: Read This Before Placing a Bet (Zacks)
Sep-05-25 12:34AM	3 Low-Volatility Stocks We Steer Clear Of (StockStory)
Sep-03-25 11:30AM	Why Is Inspire (INSP) Up 7.5% Since Last Earnings Report? (Zacks)
Sep-01-25 12:02AM	Omnicell (OMCL): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)
Aug-27-25 11:38PM	Q2 Earnings Highlights: Omnicell (NASDAQ:OMCL) Vs The Rest Of The Healthcare Technology for Providers Stocks (StockStory)
Aug-26-25 12:20PM	Earnings Estimates Rising for Omnicell (OMCL): Will It Gain? (Zacks)
09:55AM	Wall Street Analysts Believe Omnicell (OMCL) Could Rally 34.18%: Here's is How to Trade (Zacks)
Aug-25-25 04:05PM	Omnicell Appoints Baird Radford as Executive Vice President and Chief Financial Officer (Business Wire)
Aug-14-25 09:34AM	Pharmacy Automation Company Evaluation Report 2025 \| BD, Omnicell, and Capsa Healthcare Lead in Medical Technology, Pharmacy Automation, and Medication Management Solutions (GlobeNewswire)
Aug-13-25 12:04AM	OMCL Q2 Deep Dive: Product Innovation and Recurring Revenue Drive Upbeat Guidance (StockStory)
Aug-12-25 11:50PM	5 Must-Read Analyst Questions From Omnicell's Q2 Earnings Call (StockStory)
Aug-01-25 09:55AM	Wall Street Analysts See a 44.47% Upside in Omnicell (OMCL): Can the Stock Really Move This High? (Zacks)
Jul-31-25 07:45AM	Omnicell (OMCL) Beats Q2 Earnings and Revenue Estimates (Zacks)
06:59AM	Omnicell (NASDAQ:OMCL) Reports Upbeat Q2, Full-Year Outlook Slightly Exceeds Expectations (StockStory)
06:43AM	Omnicell: Q2 Earnings Snapshot (Associated Press Finance)
06:30AM	Omnicell Announces Second Quarter 2025 Results (Business Wire)

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Mar 16 '26	Sale	34.69	7,405	256,879	96,717	Mar 17 04:05 PM
Manley Corey J	Officer	Mar 16 '26	Proposed Sale	34.69	7,405	256,879		Mar 16 11:36 AM
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Feb 17 '26	Sale	36.59	4,243	155,251	85,496	Feb 18 04:05 PM
Manley Corey J	Officer	Feb 17 '26	Proposed Sale	36.59	4,243	155,251		Feb 17 10:56 AM
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Jan 08 '26	Sale	49.90	6,106	304,689	91,674	Jan 12 04:05 PM
Manley Corey J	Officer	Jan 08 '26	Proposed Sale	49.90	6,106	304,689		Jan 08 10:30 AM
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Dec 16 '25	Sale	43.30	278	12,037	97,780	Dec 17 04:05 PM
Manley Corey J	Officer	Dec 16 '25	Proposed Sale	43.30	278	12,037		Dec 16 09:48 AM
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Dec 03 '25	Sale	39.90	6,106	243,629	98,282	Dec 05 04:05 PM
Manley Corey J	Officer	Dec 03 '25	Proposed Sale	39.90	6,106	243,629		Dec 03 04:39 PM
LIPPS RANDALL A	CHAIRMAN, PRESIDENT AND CEO	Dec 01 '25	Option Exercise	27.70	28,250	782,525	414,898	Dec 03 04:05 PM
LIPPS RANDALL A	CHAIRMAN, PRESIDENT AND CEO	Dec 01 '25	Sale	35.97	28,250	1,016,093	386,648	Dec 03 04:05 PM
Randall Lipps	Officer	Dec 01 '25	Proposed Sale	35.97	28,250	1,016,092		Dec 01 01:12 PM
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Nov 17 '25	Sale	34.90	3,473	121,208	104,388	Nov 18 04:13 PM
Manley Corey J	Officer	Nov 17 '25	Proposed Sale	34.90	3,473	121,208		Nov 17 10:36 AM
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Sep 12 '25	Sale	33.25	3,880	129,010	110,653	Sep 16 04:09 PM
Manley Corey J	Officer	Sep 12 '25	Proposed Sale	33.25	3,880	129,010		Sep 12 11:36 AM

COO

Cooper Companies, Inc

OMCL

Omnicell, Inc

Upgrade your Finviz experience